Recombination in mycobacteria.
Mycobacterium tuberculosis, the causative agent of tuberculosis (TB) is thought to infect a quarter of the world's population and accounts for 3 million deaths each year. Leprosy, caused by Mycobacterium leprae continues to afflict millions. In many countries, the incidence of TB is increasing due to its association with acquired immune deficiency syndrome (AIDS) and the emergence of multidrug resistance strains of tubercle bacilli. Genes that encode major antigens, enzymes, potential virulence determinants and drug resistance in mycobacteria have been isolated and characterized; however, further genetic analysis of pathogenic mycobacteria has been severely hampered by the difficulty in precisely defining the phenotype of both wild-type and mutant genes by utilizing homologous recombination to perform allele exchange. Recombination mechanisms have been intensely studied in Escherichia coli but it is unclear how far mechanistic pathways elucidated in this species are applicable to other organisms, such as mycobacteria. The aim of this review is to examine what is currently known about homologous recombination in mycobacteria. A model is proposed to account for both low levels of homologous recombination and high levels of illegitimate recombination found in the tubercle bacillus.
McFadden
J
J
Molecular Microbiology Group, School of Biological Sciences, University of Surrey, Guildford, UK. j.mcfadden@surrey.ac.uk
D000483:Alleles; D004926:Escherichia coli / Q000235:genetics; D006801:Humans; D008957:Models, Genetic; D009161:Mycobacterium / Q000235:genetics* / Q000254:growth & development; D011938:Rec A Recombinases / Q000235:genetics; D011995:Recombination, Genetic
D011938:Rec A Recombinases